Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural killer cells and unconventional T cells in COVID-19
Niklas K. Björkström, Andrea Ponzetta
Current Opinion in Virology (2021) Vol. 49, pp. 176-182
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The Effects of COVID-19 on the Placenta During Pregnancy
Habib Sadeghi Rad, Joan Röhl, Nataly Stylianou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 86
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
Hiam Naiditch, Michael R. Betts, H. Benjamin Larman, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients
Etianne Martini Sasso, Katsuhiko Muraki, Natalie Eaton-Fitch, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 30
Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery
Vichaya Ruenjaiman, Pimpayao Sodsai, Patipark Kueanjinda, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 55, Iss. 6, pp. 993-1004
Open Access | Times Cited: 24
Invariant natural killer T cells in lung diseases
Dongjin Jeong, Yeon Duk Woo, Doo Hyun Chung
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 9, pp. 1885-1894
Open Access | Times Cited: 14
Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5
Brian Imbiakha, Shahrzad Ezzatpour, David W. Buchholz, et al.
Science Advances (2023) Vol. 9, Iss. 38
Open Access | Times Cited: 13
Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?
Mohammad Hossein Razizadeh, Alireza Zafarani, Mahsa Taghavi-Farahabadi, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Current understanding of T cell immunity against SARS-CoV-2
Xiuyuan Lu, Sho Yamasaki
Inflammation and Regeneration (2022) Vol. 42, Iss. 1
Open Access | Times Cited: 20
Innate and Innate-like Effector Lymphocytes in Health and Disease
Luc Van Kaer, J. Luke Postoak, Wenqiang Song, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 2, pp. 199-207
Open Access | Times Cited: 19
Mucosal-associated invariant T cells in infectious diseases of respiratory system: recent advancements and applications
Xue Lin, Ye Wang, Yanqi He
Journal of Inflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
The causal effect of natural killer cells on COVID-19 infection, hospitalization and severity
Kaili Yang, Jun Quan, Zhi Long Liu, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access
ScRNA-Seq reveals T cell immunity in COVID-19 patients and implications for immunotherapy
Zhihong Yao, Feng Zhao, Hui Zhang, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114663-114663
Open Access
SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamics
Nadia Siles Alvarado, Maisey Schuler, Cole Maguire, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
NK cells in COVID-19—from disease to vaccination
Quirin Hammer, Angélica Cuapio, Jonna Bister, et al.
Journal of Leukocyte Biology (2023) Vol. 114, Iss. 5, pp. 507-512
Open Access | Times Cited: 8
Early expansion of activated adaptive but also exhausted NK cells during acute severe SARS-CoV-2 infection
Maren Claus, Naomi Pieris, Doris Urlaub, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
The Humoral Immune Response to BNT162b2 Vaccine Is Associated With Circulating CD19+ B Lymphocytes and the Naïve CD45RA to Memory CD45RO CD4+ T Helper Cells Ratio in Hemodialysis Patients and Kidney Transplant Recipients
Αnila Duni, Γεώργιος Μαρκόπουλος, Ioannis Mallioras, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 19
Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients
José L. Casado, Elisa Moraga, Pilar Vizcarra, et al.
Viruses (2021) Vol. 14, Iss. 1, pp. 46-46
Open Access | Times Cited: 19
Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia: A Serologic and Cellular Study
Stefano Molica, Diana Giannarelli, Mirella Lentini, et al.
Chemotherapy (2021) Vol. 67, Iss. 2, pp. 91-95
Open Access | Times Cited: 18
Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function
Sanaz Abbaspour‐Aghdam, Ali Hazrati, Samaneh Abdolmohammadi‐Vahid, et al.
European Journal of Pharmacology (2022) Vol. 933, pp. 175267-175267
Open Access | Times Cited: 14
Exploring the Role of Innate Lymphocytes in the Immune System of Bats and Virus-Host Interactions
Wan Rong Sia, Yi‐Chao Zheng, Fei Han, et al.
Viruses (2022) Vol. 14, Iss. 1, pp. 150-150
Open Access | Times Cited: 11
Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
Abdullahi Rabiu Abubakar, Rahnuma Ahmad, Adekunle Babajide Rowaiye, et al.
Life (2022) Vol. 12, Iss. 4, pp. 478-478
Open Access | Times Cited: 11
Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?
István Vályi‐Nagy, Ferenc Uher, Éva Rákóczi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13951-13951
Open Access | Times Cited: 9
Comprehensive Analysis of the ILCs and Unconventional T Cells in Virus Infection: Profiling and Dynamics Associated with COVID-19 Disease for a Future Monitoring System and Therapeutic Opportunities
Elena Lo Presti, Andrea De Gaetano, Giovanni Pioggia, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 542-542
Open Access | Times Cited: 8
The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes
Hans‐Gustaf Ljunggren, Eivind Heggernes Ask, Martin Cornillet, et al.
Scandinavian Journal of Immunology (2022) Vol. 96, Iss. 1
Open Access | Times Cited: 4
SARS-CoV-2 Specific Antibody Response and T Cell-Immunity in Immunocompromised Patients up to Six Months Post COVID: A Pilot Study
Johanna Sjöwall, Maria Hjorth, Annette Gustafsson, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3535-3535
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top